The European biopsy device market will continue to grow modestly through 2028, driven largely by growth in the percutaneous soft tissue biopsy device market. In addition, the ongoing shift from reusable to disposable devices, coupled with improved patient perceptions surrounding biopsy procedures and screening tests, will have a significant positive impact on the market; overall, these factors will support continued market growth during the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in Europe across a 10-year period.


The European biopsy device market will continue to grow modestly over the forecast period, driven primarily by  participation in cancer screening programs.

What cancer screening programs have been launched in recent years and how have they impacted the market?

How are CRC screening programs affecting market dynamics in Europe?

How are breast cancer screening programs affecting market dynamics in Europe?

Minimally invasive, alternative technologies to tissue biopsy are being adopted by physicians in the Europe.

To what extent are physicians adopting these minimally invasive technologies?

How will the adoption of alternative technologies impact the biopsy device market?

The ongoing shift in preference from reusable to disposable devices in Europe will have a significant impact on the biopsy device market.

How do adoption rates of reusable and disposable biopsy devices vary in each of the countries covered?

How will these varying adoption rates affect the revenues generated across different European markets?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
        • Pricing Strategies and Purchasing Options
        • Local Marketing Strategies
        • Distribution and Sales Network
      • Market Developments
    • Percutaneous Soft Tissue Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Vacuum-Assisted Biopsy Devices
        • Core Needle Biopsy Devices
        • Fine Needles
      • Competitive Highlights
      • Market Share Ranking
      • Competitive Factors and Strategies
        • Physician Training and Marketing
        • Product Improvements and Innovations
    • Bone Marrow Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Gastrointestinal Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
        • Polypectomy Snares
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Bronchial Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
        • TBNA Needles
      • Competitive Highlights
      • Major Competitors
      • Competitive Factors and Strategies
    • Gynecological Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Major Competitors
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Ajeet Pratap Singh, MBA(Pharm)

Ajeet Pratap Singh is a market expert specializing in biopsy devices within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resource Group. Ajeet Singh holds a Bachelor's degree in Pharmacy from Babu Banarasi Das University, Lucknow, Uttar Pradesh, and an MBA (Pharm) from the National Institute Of Pharmaceutical Education And Research, Nagar, Punjab.


Related Reports

Biopsy Devices | Medtech 360 | Market Insights | United States

Biopsy procedure volumes will continue to grow at a modest rate through 2028, driven by favorable demographic trends, the development of more accurate testing methods,...

View Details

Breast Biopsy Devices | Medtech 360 | Market Insights | Global

The moderate growth of the global breast biopsy device market will be driven primarily by the increasing awareness of breast cancer screening in developing markets like China a...

View Details

Biopsy Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for biopsy devices will be driven primarily by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increa...

View Details